|
|||||
|
|
A report from the Food and Drug Administration identifies the causes of recent shortages of some drugs, and calls for new processes and incentives to prevent future shortages. . . . → Read More: FDA – New Processes, Incentives Needed for Drug Shortages 
A cancer center and biotechnology company are creating treatments that target proteins on immune-system cells unique to each patient. . . . → Read More: MD Anderson, Biotech Partner on T-Cell Receptors  Comments are closed  Joint ventures/collaborations  biomedical, biotechnology, cancer, genomics, life sciences, pharmaceuticals, university 
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Japan, licensing, life sciences, nanotechnology, pharmaceuticals, university 
An implanted device that senses an overdose of opioid drugs and dispenses an emergency rescue medicine is in development by two university labs. . . . → Read More: Implanted Overdose Rescue Device Being Developed Comments are closed Finance, New products biomedical, engineering, grant, life sciences, medical device, NIH, pharmaceuticals, preclinical, university 
Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects Comments are closed New products biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals, psychiatric 
Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments. . . . → Read More: Real-World Evidence Assessed for Cancer Drug Trials One comment - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, cancer, clinical trials, engineering, FDA, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease. . . . → Read More: Trial to Test CBD for Parkinson’s-Related Psychosis One comment - (Comments are closed) New products biomedical, clinical trials, Europe, life sciences, pharmaceuticals, psychiatric, U.K., university 
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier One comment - (Comments are closed) New products biomedical, biotechnology, engineering, entrepreneurs, Europe, genomics, life sciences, nanotechnology, pharmaceuticals, preclinical, U.K., university 
A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy Comments are closed Joint ventures/collaborations biomedical, biotechnology, Europe, genomics, life sciences, pharmaceuticals 
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, genomics, licensing, life sciences, pharmaceuticals, preclinical, U.K. |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
